Sanjana Bukkapatnam

发表

EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment

S. Karam, R. Ferris, Olga C. Rodriguez, 2022, Nature Communications.

Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma

S. Karam, C. Albanese, R. Vibhakar, 2017, Cancer Cell International.

Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers

A. Jimeno, S. Karam, D. Raben, 2018, Clinical Cancer Research.

Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor

S. Karam, D. Raben, L. Heasley, 2018, Molecular Cancer Therapeutics.

Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma

S. Karam, Laurel B. Darragh, A. Oweida, 2021, Cancer Immunology, Immunotherapy.

The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.

S. Karam, D. Cittelly, R. Vibhakar, 2020, Molecular carcinogenesis.

Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration

S. Karam, A. Tan, D. Raben, 2018, Clinical Cancer Research.

Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma

S. Karam, C. Albanese, R. Vibhakar, 2017, Cancer Cell International.

Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC

S. Karam, P. Umaña, Christian Klein, 2023, Cell reports. Medicine.

Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs.

A. van Bokhoven, Molishree Joshi, Nicholas A. Olimpo, 2024, Med.